Terms: = Ovarian cancer AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
8 results:
1. Cost-Effectiveness Analysis of Adjuvant Endocrine Therapy With ovarian Suppression in Premenopausal Patients With Hormone Receptor-Positive Early Breast cancer in China.
Zhong X; Chen P; He P; Wu Y; Suo J; Zhu K; Yan X; Tian T; Yang Q; Luo T
Clin Breast Cancer; 2024 Feb; 24(2):e41-e50. PubMed ID: 37865566
[TBL] [Abstract] [Full Text] [Related]
2. PTEN mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
[TBL] [Abstract] [Full Text] [Related]
3. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
[TBL] [Abstract] [Full Text] [Related]
4. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium.
Gonthier C; Trefoux-Bourdet A; Koskas M
Int J Gynecol Cancer; 2017 Mar; 27(3):493-499. PubMed ID: 28187090
[TBL] [Abstract] [Full Text] [Related]
6. Malnutrition Identified by the Nutritional Risk Index and Poor Prognosis in Advanced Epithelial ovarian Carcinoma.
Yim GW; Eoh KJ; Kim SW; Nam EJ; Kim YT
Nutr Cancer; 2016 Jul; 68(5):772-9. PubMed ID: 27044606
[TBL] [Abstract] [Full Text] [Related]
7. Clinical evaluation of human granulocyte colony-stimulating factor in chemotherapy for ovarian cancer.
Nagai N; Takehara K; Murakami T; Ohama K; Miyaoka S; Fujii T; Matsubayashi S
Hiroshima J Med Sci; 1995 Dec; 44(4):99-103. PubMed ID: 8857232
[TBL] [Abstract] [Full Text] [Related]
8. A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.
Howell SB; Kirmani S; Lucas WE; Zimm S; Goel R; Kim S; Horton MC; McVey L; Morris J; Weiss RJ
J Clin Oncol; 1990 Jan; 8(1):137-45. PubMed ID: 2295904
[TBL] [Abstract] [Full Text] [Related]
